Chinook Will Soon Have $275m To Advance Kidney Disease Strategy

Company’s Reverse Merger, New Financing Will Fund Four Clinical Trials

 
• By Mandy Jackson

Chinook launched less than two years ago to develop precision medicines for chronic kidney diseases and will have three drugs in the clinic in 2021, including a Phase III candidate for IgA nephropathy.

Image of human hands holding plant shaped like dollar
Chinook raised $65m last year but will have $275m later this year • Source: Shutterstock

More from Financing

More from Business